Results 1 to 10 of about 5,102 (175)
A short-course of low-dose insulin detemir effectively decreases blood glucose levels in gestational diabetic women undergoing dexamethasone treatment to promote newborn lung maturity. [PDF]
Medicine (Baltimore)Pregnant women with gestational diabetes mellitus undergoing glucocorticoid treatment to prevent neonatal respiratory distress syndrome could have increased glucose level.
Wu WZ +6 more
europepmc +2 more sources
Comparison of treatment with insulin detemir and NPH in women with gestational diabetes mellitus: glycemic control and pregnancy outcomes. A retrospective study. [PDF]
Hormones (Athens), 2023 Purpose The objective of this retrospective study was to compare glycemic control, pregnancy outcomes, and neonatal outcomes in women with gestational diabetes mellitus (GDM) treated with (a) insulin detemir and (b) insulin neutral protamine Hagedorn ...
Kazakou P +5 more
europepmc +2 more sources
Molecules, 2017 The aim of the present study is to quantitatively assess the expression of selected regulatory molecules, such as leptin, leptin receptor, and adiponectin in the blood of obese patients with type 2 diabetes both before treatment and after six months of ...
Paweł Olczyk +9 more
doaj +2 more sources
Sustained Treatment with Insulin Detemir in Mice Alters Brain Activity and Locomotion. [PDF]
PLoS ONE, 2016 AIMS:Recent studies have identified unique brain effects of insulin detemir (Levemir®). Due to its pharmacologic properties, insulin detemir may reach higher concentrations in the brain than regular insulin.
Tina Sartorius +3 more
doaj +1 more source
Detemir improves diabetic regulation in poorly controlled diabetic dogs with concurrent diseases.
Journal of the American Veterinary Medical Association, 2023 OBJECTIVE This study evaluated the use of detemir for treating diabetic dogs with comorbidities that were poorly controlled with intermediate-acting insulins. ANIMALS 7 insulin-treated diabetic dogs. PROCEDURES Retrospective pilot study.
Antoinette R Harris-Samson +2 more
semanticscholar +1 more source
Probing the mechanism of reduced in vivo potency of insulin detemir
Expert Opinion on Drug Metabolism & Toxicology, 2023 Background Insulin detemir (IDet) is an insulin analog used to treat diabetes. IDet shows full efficacy but reduced potency compared to human insulin (HI) in both man and rat. In contrast, in pigs and dogs, IDet appears to have full in vivo potency.
C. L. Brand, J. Sturis
semanticscholar +1 more source
Crystals, 2023 The treatment of insulin-dependent diabetes mellitus is characterized by artificial supplementation of pancreatic β-cell ability to regulate sugar levels in the blood.
Esra Ayan +5 more
doaj +1 more source
Jurnal Ilmiah Farmasi, 2023 Latar belakang: Berdasarkan International Diabetes federation (IDF) prevalensi diabetes tahun 2030 berkisar 438 juta orang. Glukosa darah sewaktu adalah kadar glukosa yang dilakukan seketika waktu tanpa harus puasa. Hba1c adalah parameter standar dalam
Helmina Wati +5 more
semanticscholar +1 more source
Frontiers in Endocrinology, 2022 The management of diabetes mellitus in an insulin-dependent patient is challenging in the setting of concomitant antibody-mediated-insulin hypersensitivity.
C. B. Teo +11 more
semanticscholar +1 more source
Journal of Diabetes and Endocrine Practice, 2022 Objectives The aim of this study was to compare between insulin glargine and insulin detemir on glucose profile in adolescents with type 1 diabetes mellitus (T1DM) who fast the month of Ramadan.
W. Kaplan +2 more
semanticscholar +1 more source